Journal of Dental Research

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chen, S.
Right arrow Articles by Wang, C.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Dental Research, Vol. 81, No. 2, 98-102 (2002)
DOI: 10.1177/154405910208100203

Potentiation of Tumor Necrosis Factor-mediated Apoptosis of Oral Squamous Cell Carcinoma Cells by Adenovirus-mediated Gene Transfer of NF-{kappa}B Inhibitor

S. Chen1, A. Fribley1,2 and C.-Y. Wang1,*,2,3

1 Laboratory of Molecular Signaling and Apoptosis, Department of Biologic and Materials Science,
2 Program in Oral Health Science, School of Dentistry, and
3 Program in Cellular and Molecular Biology, University of Michigan, 1011 N. University Ave., Ann Arbor, MI 48109-1078;


Figure 1
View larger version (72K):
[in this window]
[in a new window]

 
Figure 1. Expression of SR-I{kappa}B{alpha} by adenovirus-mediated gene transfer inhibits phosphorylation of I{kappa}B{alpha} induced by TNF. (A) Expression of SR-I{kappa}B{alpha} after Adv-SR-I{kappa}B{alpha} transduction. SCC15 cells were infected with adenoviruses expressing SR-I{kappa}B{alpha} or LacZ at a MOI of 200 for 4 hrs. Twenty-four hrs after infection, cells were treated with TNF (10 ng/mL) for the indicated time points. The whole-cell proteins were extracted and probed with polyclonal antibodies against I{kappa}B{alpha}. (B) SR-I{kappa}B{alpha} inhibited phosphorylation of I{kappa}B{alpha} induced by TNF. Both viral infection and cell treatment were performed as described in (A). Whole-cell extracts were probed with polyclonal antibodies against phospho-specific I{kappa}B{alpha}. As an internal control, the blots were stripped and re-probed with monoclonal antibodies against {alpha}-tubulin.

 

Figure 2
Figure 2
View larger version (168K):
[in this window]
[in a new window]

 
Figure 2. Adv-SR-I{kappa}B{alpha} sensitizes SCC 15 cells to TNF killing. (A) Photograph of cells after TNF treatment. Cells were infected with Adv-SR-I{kappa}B{alpha} or Adv-LacZ as described in Fig. 1AGo. One day later, cells were treated with TNF (10 ng/mL) for 24 hrs and photographed under phase-contrast microscopy. (B) SR-I{kappa}B{alpha} sensitized cells to TNF killing. After TNF treatment, cells were harvested and incubated with 0.1% trypan blue. Dead and living cells were counted separately. Assays were performed in triplicate, and the results represent average values from three independent experiments. Statistical differences between groups were determined by Student's t test. Error bars represent standard deviation. *p < 0.01. (C) SR-I{kappa}B{alpha} enhances TNF-induced DNA fragmentation. Supernatants from (B) were collected and measured with a cell death ELISA kit. Assays were performed in duplicate, and the results represent average values from three independent experiments. Statistical differences between groups were determined by Student's t test. Error bars indicate standard deviation. *p < 0.01.

 

Figure 3
View larger version (12K):
[in this window]
[in a new window]

 
Figure 3. Adv-SR-I{kappa}B{alpha} renders oral SCC5 cells sensitive to TNF killing. Both viral infection and TNF treatment were performed as described in Fig. 2Go. Cells were harvested and incubated with 0.1% trypan blue. Dead and living cells were counted separately. Assays were performed in duplicate, and the results represent average values from three independent experiments. Error bars represent standard deviation. *p < 0.01.

 

Figure 4
View larger version (33K):
[in this window]
[in a new window]

 
Figure 4. TNF activates the caspase cascade in SCC cells after Adv-SR-I{kappa}B{alpha} transduction. (A) TNF induces caspase-8 activity after Adv-SR-I{kappa}B{alpha} transduction. Viral infection was performed as described in Fig. 1AGo. After infection, cells were treated with TNF (10 ng/mL) for the indicated time points. Whole-cell extracts were prepared and incubated with the specific caspase-8 substrate pNA-IETD (100 µM) at 37°C for 8 hrs. The reaction was measured with a plate reader at 405 nm. Assays were performed in triplicate, and the results represent average values from two independent experiments. Statistical differences between groups were determined by Student's t test. Error bars represent standard deviation. *p < 0.01. (B) TNF induces caspase-3 activity after Adv-SR-I{kappa}B{alpha} transduction. Whole-cell extracts were incubated with the specific caspase-3 substrate pNA-DEVD (100 µM) at 37°C for 16 hrs. Error bars represent standard deviation. *p < 0.01.

 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?